Well Told Grants

Federal grant recipients / Massachusetts

Federal grants to Beth Israel Deaconess Medical Center, Inc.

Boston, Massachusetts · Nonprofits · UEI C1CPANL3EWK4

Beth Israel Deaconess Medical Center, Inc. in Boston, Massachusetts received $702 million in federal grants from fiscal 2021 to 2025, across 486 awards. Its largest program was Cardiovascular Diseases Research, with $139 million. In fiscal 2025 it was awarded $152 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Beth Israel Deaconess Medical Center, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 2021247$143 million
FY 2022246$139 million
FY 2023238$133 million
FY 2024236$134 million
FY 2025232$152 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Beth Israel Deaconess Medical Center, Inc.

The 10 largest programs, fiscal 2021 to 2025
ProgramAwardsAmount
Cardiovascular Diseases Research 93.83781$139 million
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.84778$104 million
Allergy and Infectious Diseases Research 93.85533$81.6 million
Aging Research 93.86646$64.9 million
Extramural Research Programs in the Neurosciences and Neurological Disorders 93.85336$41.4 million
Cancer Biology Research 93.39619$39.1 million
Military Medical Research and Development 12.42021$32.6 million
Cancer Treatment Research 93.39518$25.9 million
Mental Health Research Grants 93.24221$17.6 million
Trans-NIH Research Support 93.31016$16.5 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services451$664 million
Department of Defense21$32.6 million
National Science Foundation7$2.5 million
National Aeronautics and Space Administration6$2.1 million
Department of Justice1$918,800

Largest awards

The 10 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
I4C 2.0: immunotherapy for cure - summary the goals of I4C 2.0 are to advance our scientific understanding of the viral reservoir and to develop immunologic strategies for HIV-1 remission and eradication by a highly collaborative and multifaceted research program involving partnerships among academi
ASST_NON_UM1AI164556_075 on USAspending
Allergy and Infectious Diseases ResearchAugust 13, 2021$20.0 million
Mechanisms of sleep and sleep apnea
ASST_NON_P01HL149630_075 on USAspending
Cardiovascular Diseases ResearchDecember 28, 2020$13.6 million
Generation of a cellular atlas of adipose tissue in mouse and man
ASST_NON_RC2DK116691_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchMarch 10, 2021$10.2 million
Df/hcc renal cancer spore
ASST_NON_P50CA101942_075 on USAspending
Cancer Centers Support GrantsDecember 2, 2020$10.1 million
Data-driven sleep biomarkers of brain health, heart health, and mortality - abstract: data-driven sleep biomarkers of brain health, heart health, and mortality sleep state signals encode critical biological information about brain and cardiovascular health. However, present approaches to polysomnogr
ASST_NON_R01HL161253_075 on USAspending
Cardiovascular Diseases ResearchAugust 15, 2022$8.3 million
Consortia for innovative AIDS research in nonhuman primates
ASST_NON_UM1AI124377_075 on USAspending
Allergy and Infectious Diseases ResearchNovember 18, 2020$8.1 million
AD26 based therapeutic vaccines for HIV
ASST_NON_U01AI145801_075 on USAspending
Allergy and Infectious Diseases ResearchApril 29, 2021$7.5 million
Sensory phenotyping to enhance neuropathic pain drug development - project summary / abstract despite the high prevalence and impact of neuropathic pain (NP), patients have only a 30% probability of meaningful response to any single medication. Furthermore, it is not known which patients will respon
ASST_NON_UH3NS130592_075 on USAspending
Drug Use and Addiction Research ProgramsAugust 5, 2025$7.1 million
Aryl hydrocarbon receptor innate immune modulators for treatment of inflammatory bowel disease
ASST_NON_W81XWH2110369_097 on USAspending
Military Medical Research and DevelopmentMay 14, 2021$6.8 million
Statins use in intracerebral hemorrhage patients (SATURN)
ASST_NON_U01NS102289_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersApril 29, 2022$6.6 million

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Beth Israel Deaconess Medical Center, Inc. get?

$702 million in 486 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Beth Israel Deaconess Medical Center, Inc. the most?

The Department of Health and Human Services, with $664 million in 451 awards. The Department of Defense and the National Science Foundation follow.

What is Beth Israel Deaconess Medical Center, Inc.'s largest federal grant?

$20.0 million under Allergy and Infectious Diseases Research, with its first action in the period on August 13, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Beth Israel Deaconess Medical Center, Inc.?

Its largest are Cardiovascular Diseases Research, Diabetes, Digestive, and Kidney Diseases Extramural Research and Allergy and Infectious Diseases Research.

Other grant recipients in Boston

Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts